|
revascularization with drug eluting stent in coronary artery disease - Clinical trials results
Systematic review and meta-analysis of clinical trials
about revascularization with drug eluting stent in coronary artery disease.
Clinical trials enrolled the following type of patients :
See also:
-
revascularization with drug eluting stent (all clinical conditions)
-
coronary artery disease (all therapeutical action or mecanism)
- Other revascularization with drug eluting stent:
A
,
abciximab-coated stent
,
biodegradable-polymer sirolimus stent
,
biolimus A9
,
biolimus ES
,
CoStar stent
,
crush stenting
,
dactinomycin ES
,
DES
,
dexamethasone ES
,
drug ES
,
dual sirolimus, probucol ES
,
everolimus ES
,
Genous stent
,
kissing balloon
,
paclitaxel eluting balloon
,
paclitaxel ES
,
paclitaxel, non-polymeric ES
,
PCI
,
pimecrolimus ES
,
polymer free sirolimus stent
,
sirolimus biodegradable polymer
,
sirolimus ES
,
titanium-nitride-oxide coated stent
,
zotarolimus ES
,
-
Drug Coated Stents in coronary artery disease
-
Drug-Eluting Stents in coronary artery disease
-
revascularization with drug eluting stent in Coronary Artery Disease
-
revascularization with drug eluting stent in angor
-
revascularization with drug eluting stent in stable angina
-
revascularization with drug eluting stent in Coronary Arteriosclerosis
-
revascularization with drug eluting stent in Coronary Atherosclerosis
-
revascularization with drug eluting stent in Myocardial Ischemia
-
revascularization with drug eluting stent in Ischemic Heart Diseases
Entry term : Coronary Artery Disease, angor, stable angina, Coronary Arteriosclerosis, Coronary Atherosclerosis, Myocardial Ischemia, Ischemic Heart Diseases, , Drug Coated Stents, Drug-Eluting Stents
citeULike
|